Advances in Meningioma Diagnosis and Treatment: A Comprehensive Review
DOI:
https://doi.org/10.63666/ejsmr.1694-9013.1.I.2025.3Keywords:
meningioma, radiotherapy, diagnosis, treatment, surgeryAbstract
Meningiomas, the most prevalent primary intracranial tumors, account for over one-third of brain neoplasms. Though often benign, their diagnosis and treatment are complex due to variability in clinical presentation, anatomical location, and biological behavior. This review examines cutting-edge diagnostic tools, including MRI, PET, and molecular profiling, alongside treatment modalities such as surgery, radiotherapy, and emerging targeted therapies. We address challenges in managing atypical and malignant meningiomas, emphasizing recurrence and resistance to conventional approaches. The integration of multidisciplinary strategies and future research directions, including immunotherapy and precision medicine, are highlighted as critical for improving patient outcomes.
References
1. Ostrom, Q. T., Price, M., & Neff, C. (2023). CBTRUS statistical report: Primary brain and other central nervous system tumors diagnosed in the United States in 2015–2019. Neuro-Oncology, 25(Supplement_4), iv1–iv99. https://doi.org/10.1093/neuonc/noad149
2. Louis, D. N., Perry, A., & Wesseling, P. (2021). The 2021 WHO classification of tumors of the central nervous system: A summary. Neuro-Oncology, 23(8), 1231–1251. https://doi.org/10.1093/neuonc/noab106
3. Wiemels, J., Wrensch, M., & Claus, E. B. (2010). Epidemiology and etiology of meningioma. Journal of Neuro-Oncology, 99(3), 307–314. https://doi.org/10.1007/s11060-010-0386-3
4. Goldbrunner, R., Minniti, G., & Preusser, M. (2020). EANO guidelines for the diagnosis and treatment of meningiomas. Lancet Oncology, 21(9), e416–e425. https://doi.org/10.1016/S1470-2045(20)30396-5
5. Rogers, L., Barani, I., & Chamberlain, M. (2021). Meningiomas: Knowledge base, treatment outcomes, and future directions. Neuro-Oncology, 23(Supplement_1), i1–i12. https://doi.org/10.1093/neuonc/noab028
6. Nabavizadeh, S. A., Akbari, H., & Davatzikos, C. (2019). Advanced imaging techniques in meningioma: Beyond conventional MRI. American Journal of Neuroradiology, 40(8), 1298–1305. https://doi.org/10.3174/ajnr.A6123
7. Galldiks, N., Albert, N. L., & Langen, K. J. (2022). Role of PET imaging in meningioma diagnosis and management. Current Opinion in Neurology, 35(6), 765–772. https://doi.org/10.1097/WCO.0000000000001103
8. Bi, W. L., Zhang, M., & Wu, W. W. (2021). Emerging molecular therapies for meningiomas: Current perspectives and future directions. Neurosurgery Clinics of North America, 32(2), 241–251. https://doi.org/10.1016/j.nec.2020.11.006
9. Sheehan, J. P., Starke, R. M., & Kano, H. (2015). Stereotactic radiosurgery for meningiomas: A review of outcomes and complications. Journal of Neurosurgery, 122(5), 1018–1027. https://doi.org/10.3171/2014.10.JNS141428
10. Aizer, A. A., Arvold, N. D., & Catalano, P. J. (2019). Adjuvant radiotherapy for atypical and malignant meningiomas: A systematic review. Neuro-Oncology, 21(5), 628–636. https://doi.org/10.1093/neuonc/noz014
11. Kaley, T., Barone, D., & McDermott, M. (2018). Management of recurrent meningiomas: Systemic therapies and future directions. Neuro-Oncology Practice, 5(3), 141–150. https://doi.org/10.1093/nop/npy013
12. Graillon, T., Romano, D., & Dufour, H. (2020). Somatostatin analogs in the management of meningiomas: A systematic review. Journal of Neuro-Oncology, 149(1), 1–10. https://doi.org/10.1007/s11060-020-03562-8
13. Shih, K. C., Chowdhary, S., & Rosenblatt, P. (2016). Bevacizumab in recurrent meningiomas: A retrospective study. Journal of Neuro-Oncology, 130(1), 133–140. https://doi.org/10.1007/s11060-016-2238-8
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Eurasian Journal of Scientific and Multidisciplinary Research
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
